Statistics
Publications
1
Citations
16
H-Index
1
Active since
2018
Affiliations
Emcure Pharmaceuticals (India)(Current)
Ramamohan Reddy Lekkala is an author at Emcure Pharmaceuticals (India) specializing in checkpoint inhibitor therapy, indoleamine 2, 3-dioxygenase pathway, and immune checkpoint inhibitors.
Publications per year
2018–2018
1
1
1–1 of 1